Article
<span class="word">Peripheral <span class="word">Inflammatory <span class="word">Biomarkers <span class="word">in <span class="word">First-<span class="word"><span class="changedDisabled">Episode, <span class="word">Drug-<span class="word"><span class="changedDisabled">Naïve <span class="word">Major <span class="word">Depressive <span class="word">Disorder: <span class="word">A <span class="word">Systematic <span class="word">Review
2026-05-15
Abstract excerpt
Major depressive disorder (MDD) is clinically heterogeneous, and peripheral inflammatory biomarkers may help clarify early biological mechanisms before illness chronicity or pharmacologic treatment confound interpretation. This systematic review synthesized evidence on peripheral inflammatory biomarkers in first-episode, drug-naïve major depressive disorder (FEDN-MDD) compared with healthy controls and examined as...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 96a29baf-a99c-5b06-86b1-7e32a861ce1f
- DOI
- 10.20944/preprints202605.1077.v1
